The Indian government is inviting stakeholder feedback on a draft policy framework for allowing trial sponsors to undertake controlled human infection studies (CHIS) in which healthy volunteers are intentionally exposed to a specific pathogen or infectious agent under controlled conditions.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?